Asia Pacific Medical Collagen Market

Market Introduction

Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. It is bio-compatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. Collagen is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Hence collagen is widely used as a biomaterial in the medical industry.

Asia Pacific Medical Collagen Strategic Insights

Strategic insights for the Asia Pacific Medical Collagen provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Medical Collagen Report Scope

Asia Pacific Medical Collagen Regional Insights

The geographic scope of the Asia Pacific Medical Collagen refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Asia Pacific medical collagen market is expected to reach US$ 188.51 million by 2028 from US$ 118.73 million in 2021; it is estimated to register a CAGR of 6.8% from 2021 to 2028. The growth of the Asia Pacific medical collagen market is attributable to rising applications of collagen in the medical industry, surging disposable income, and growing middle-class population worldwide. However, medical collagen product recalls are hindering the growth of the market.

A medical product with collagen as a part is being studied to treat several conditions. Owing to its clinical and consumer acceptance, it is widely used as medical material. Collagen- based medical products such as bioprosthetic heart valves, arterial replacements, sutures used in surgical procedures, and wound dressings have been widely adopted. Thus, several research studies are being conducted to develop new collagen-based medical products. For instance, in 2020, MPM Medical initiated its CoMatryx Surgical Bovine Collagen Study. CoMatryx surgical collagen powder is a soft tissue repair product made of 100% Type-I Bovine collagen. Furthermore, research is being conducted to discover new sources of collagen for medical biomaterials. For instance, the study ‘Tilapia (Oreochromis aureus) Collagen for Medical Biomaterials’ was published in 2018. The researchers studied the potentials of tilapia skin as an alternative source of collagen for its application in medical biomaterial. Thus, the increasing research activities for collagen-based medical products are likely to drive the growth of the market during the forecast period. Also, the surge in disposable income, introduction of advanced technologies, and better aftercare have uplifted the number of cosmetic procedures being performed. Multinational corporations in the skin aesthetic industry have been prominently targeting India's huge population. As per the World Economic Forum, the number of households in India with disposable incomes of over US$ 10,000 increased 20-folds, from 2.5 million in 1990 to ~50 million in 2015. Thus, the growth in disposable income has enabled them to afford high-cost healthcare procedures such as cosmetic, orthopedic, and dental procedures thereby propelling the market growth.

Countries in Asia Pacific are facing challenges due to the increasing number of COVID-19 positive patients. The current scenario of COVID-19 pandemic has driven the governments to predominantly concentrate on containing the spread to COVID-19, due to which the focus on cosmetic treatments has temporarily drifted. The dermatology clinics, hospitals, and surgical centers are open for only emergency services. Also, medical tourism has declined in response to the pandemic in countries such as South Korea and Japan, thereby having a negative impact on the cosmetic industry and consequently affected the performance of the medical collagen market in Asia Pacific.

Key Market Segments

The Asia Pacific medical collagen market, by source, is segmented into bovine, porcine, and others. The bovine segment held the largest share of the market in 2020 and is expected to register the highest CAGR during the forecast period.

The Asia Pacific medical collagen market, by product, is segmented into gelatine, hydrolyzed collagen, native collagen, and others. The gelatine segment held the largest share of the market in 2020 and is expected to register the highest CAGR during the forecast period.

Based on application, the Asia Pacific medical collagen market is segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and others. The wound care segment held the largest share of the market in 2020. However, the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Asia Pacific medical collagen market are the World Economic Forum, Australian Institute of Health and Welfare (AIHW) and Organization for Economic Co-operation and Development (OECD).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Asia Pacific medical collagen market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Asia Pacific medical collagen market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific medical collagen market.

ASIA PACIFIC MEDICAL COLLAGEN MARKET SEGMENTATION

By Source

• Bovine
• Porcine
• Others

By Product

• Gelatine
• Hydrolysed Collagen
• Native Collagen
• Others

By Application

• Wound Care
• Bone Grafts
• Tissue Scaffolds
• Cartilage Repair
• Haemostats
• Diagnostics
• Vascular Grafts
• Other

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Company Profiles

• ENCOLL Corp
• GELITA AG
• Collagen Matrix, Inc.
• Integra Life Sciences Corporation
• Croda International plc